Latest News about EPZM
Recent news which mentions EPZM
Stocks That Hit 52-Week Lows On Friday
November 06, 2020
From Benzinga
12 Healthcare Stocks Moving In Friday's Pre-Market Session
November 06, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
Earnings Scheduled For November 6, 2020
November 06, 2020
From Benzinga
84 Biggest Movers From Yesterday
August 05, 2020
From Benzinga
The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans
August 04, 2020
From Benzinga
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
August 02, 2020
From Benzinga
From Benzinga
75 Biggest Movers From Friday
June 22, 2020
From Benzinga
50 Stocks Moving In Friday's Mid-Day Session
June 19, 2020
From Benzinga
Tickers
EPZM
From Motley Fool
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
June 18, 2020
From Benzinga
2 Top Cancer Treatment Stocks to Buy in June
June 16, 2020
From Motley Fool
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke And Ultragenyx
June 14, 2020
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
3 Cancer Treatment Stocks to Buy Right Now
March 19, 2020
From Motley Fool
Smart Money Is Clamoring to Own This Cancer-Fighting Biotech
March 09, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For March 4, 2020
March 04, 2020
From Benzinga
77 Biggest Movers From Yesterday
February 25, 2020
From Benzinga
55 Stocks Moving In Monday's Mid-Day Session
February 24, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.